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Maternal Factors, Medications, and Drug
Exposure in Congenital Limb Reduction
Defects
by Ursula G. Froster1 and Patricia A. Baird2
Aspartofanongoingstudyonall limbreductiondefects occurringamong1,213,913consecutivelivebirths in
the province ofBritish Columbia, Canada, during 1952-1984, cases with documented maternal drug exposure
and chronic maternal diseases were analyzed separately. This population-based study was made possible
through the existence of an ongoing Health Surveillance Registry, which documents all infants born with
congenital,genetic,orchronicallyhandicappingconditions intheprovinceofBritishColumbia.Strictrulesof
confidentiality are obeyed. For this part of the analysis of limb reduction defects, cases with documented
maternal illness, drug abuse, and exposure to environmental hazards early in pregnancy were analyzed as a
separate group to identify specific, recurring patterns ofanomalies. A total of51 cases with possibly related
maternal factors were identified. Among them were five cases with maternal epilepsy, four cases with
documented maternal diabetes, and three cases with uterine anomalies. Three infants, all born in 1962, had
documented thalidomide exposure. It is rarely possible to identify particular teratogenic factors or specific
maternal factors as etiologically related to the pattern oflimb reduction defects or a spectrum ofcongenital
malformations. Exposure to environmental factors during pregnancy is not reliably registered and can thus
only occasionally be ascertained in retrospective studies. This means that very large numbers of cases and
cross-referencing to other family members are required to assess whether a potential teratogen is related to
limb defects or not.
Introduction
Limb reduction defects are regarded as indicators for
teratogens and are easily recognizable and not often
missed. A number of teratogens etiologically related to
defects of limb development have been identified to date.
Not all ofthese teratogens cause a highly specific pattern
of limb reduction defects. The most widely known
teratogen causing limb reduction defects is certainly tha-
lidomide (1), but other limb reduction defect patterns have
been associated with prenatal exposure to hydantoin (2),
ethanol (3), cocaine (4), and possibly mechanical vascular
disruption by early chronic villus sampling (5).
If a chemical is involved, the resulting limb reduction
defects may be very specific. Thus, thalidomide would
cause intercalary transverse defects ("phocomelia"), while
hydantoin causes defects ofthe terminal phalanges. With
regardtoethanol,theamountconsumedandtheindividual
biological background are also additional factors in the
expression of defects. The ethanol related spectrum of
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limb reduction anomalies ranges from very severe forms
such as amelia, ectrodactyly, and unilateral terminal
transverse defects of the hand to hypoplastic end pha-
langes or small fingernails (3).
Material and Methods
The data are derived from a large study on limb reduc-
tiondefects occurringin1,213,913 consecutivelivebirthsin
the province ofBritish Columbia during a 30-year period
from 1952 to 1984 (6). The study was made possible
through the existence of a Health Surveillance Registry
(Registry) that collects information on all infants born
withmalformations, genetic diseases, orindividuals devel-
oping chronically handicapping conditions. The Registry
receives information from over 60 different sources, the
most important ones for the present study being the
PhysiciansNoticeofBirthand Hospitalseparation sheets.
Within the Registry cases are coded according to the
ninth revision of the International Classification of Dis-
eases code of the World Health Organization. Incoming
cases are cross-referenced to any other family members
alreadyregistered.Therefore,ifamotherofaninfantborn
with a malformation is registered to have a congenital
malformation or chronically handicapping condition, thisFROSTER AND BAIRD
information is identified. Details ofthe organization ofthe
Registry have been reported previously (6,7).
Incidence rates for various categories oflimb reduction
defects, and analysis of upper and lower limb defects
aimed atidentifyingspecificpatterns ofcongenital malfor-
mations have been published previously (6,8). However, the
aspect ofpossible teratogenic exposures and their role in
limb defect causation required a more detailed evaluation.
Because ofthe rules ofstrict confidentiality at the Regis-
try, it is not possible to personally examine patients.
Therefore, those cases with a documented chronic mater-
nalillness, and documented drug exposure or acute mater-
nal illness during pregnancy were extracted from the
complete body of data. These cases were evaluated for
possible common patterns ofanomalies, both ofthe limbs
andother organ systems, seenafter exposure toparticular
maternal factors. It is recognized that more mothers of
infants with limb defects in the study may also have had
similar exposure ormaternal factors present, but this fact
is not recorded. Even though ascertainment ofthese fac-
tors is therefore incomplete, there is no reason to expect
this would necessarily invalidate any pattern observed.
Results
The results are summarized in Tables 1-5. Nine cases
with prenatal ethanol exposure were described previously
and are thus notincluded (3). There remained a total of51
cases, which were divided into four subgroups based on
similar etiological factors: a) chronicmaternal diseases, b)
maternal congenital anomalies, c) acute maternal infec-
tions in pregnancy, d) exposure to medications, X-rays,
environmental hazards, or drugs in pregnancy.
Chronic Maternal Diseases
Maternaldiabetes wasregisteredinfour cases (Table1);
three males and one female. Three of these infants had
intercalary defects of the femur or tibiae. One had addi-
tional anomalies of the vertebrae, a pattern that is well
recognized as occurring in conjunction with maternal
diabetes mellitus and described as caudal regression or
unusual-facies-femoral hypoplasia syndrome (9). In one
case, defects ofthe toes and aVSD were found in addition.
Maternal epilepsy was registered in five cases (Table2),
with phenobarbital or Dilantin being specifically men-
tioned as the medication taken for this condition in three
cases. In the remaining cases, no information about the
particularmedication couldbe obtained fromthe Registry.
Limb reduction defects in this group were fairly homoge-
nous, with four out of the five patients presenting with
reduction defects ofthe distal phalanges, either on the left
side or bilateral. One infant was also noted to have epi-
lepsy. In two cases other features of the fetal-hydantoin
syndrome were specifically mentioned, but because of
Registry policy it was not possible to go back to the other
individual cases and examine them for particular features
of the fetal-hydantoin syndrome. Other maternal chronic
diseases included one case each ofarthritis, asthma, lupus
erythematosus, coeliac disease, and elevated testosterone
levels (Table 3).
Maternal Congenital Anomalies
Congenital defects were registered in mothers of 10
infants (Table 4). Four of them had skeletal anomalies,
which may thus be genetic limb defects with variable
Table 1. Cases with limb reduction defects and maternal diabetes.
Case Sex Year ofbirth Limb defect Other anomalies
1 M 1969 Intercalary, femora Hemivertebrae L4, club feet
2 M 1980 Ti, tibia, fibula, left Inguinal herniae, right, left, caudal regression
3 F 1981 Ti, phalanges, left, upper Low-set ears, microtia, left, VSD, prematurity
4 M 1983 Intercalary, femur, left Cryptorchidism, dimple over right knee, prematurity
lTble 2. Cases with limb reduction defects where the mother had epilepsy.
Case Sex Year ofbirth Maternal medication Limb defect Other anomalies
1 F 1952 None Tt, hand, left
2 F 1953 None Ti, thumb, left, distal Deafness, short stature
3 F 1957 None Tl, phalanges IV, V, bilateral, distal Hypertelorism, epilepsy
4 M 1982 Phenobarbital, Tegretal, Dilantin Tl, phalange V, left, distal Broad nose
5 M 1983 Phenobarbital, Dilantin Tt, phalange, distal, bilateral
Table 3. Chronic maternal diseases and limb reduction defects.
Case Sex Year ofbirth Maternal disease Limb defect Other anomalies
1 M 1971 Asthma Tl, phalanges I-IV, left
2 M 1974 Lupus erythematosus It, femur, right Brother: CHD
3 M 1979 Arthritis Tl, phalanges II-V, right, left
4 F 1983 Coeliac disease Tt, hand, right Cousin: Tt, radius, right
5 F 1983 Elevated testosterone levels Tl, phalanges I-IV, right Prematurity 46, XX, dysmorphic face,
seizures, hemangioma on chest,
pulmonary stenosis, clitoromegaly
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Table 4. Cases with limb defects and maternal congenital anomalies.
Case Sex Year ofbirth Maternal anomalies Limb defects Other anomalies
1 F 1955 Tl, toe V, right, left Tl, toes, V, left Brother: short fingers; maternal
grandmother: syndactyly
2 F 1973 Amniotic bands Tt, hand, right, left Asymmetric face mishapen ears,
encephalocele, esophageal
atresia, constriction bands
3 F 1980 Il, thumbs, bilateral cleft palate, Tl, phalange, II, right
syndactyly II/III toes
4 M 1983 Congenital deformity, right arm Tl, phalange, II, right
5 M 1981 Cleft palate It, radius, left syndactyly Hip dysplasia, prematurity
6 F 1976 ASD Tt, femur, right Esotropia, bilateral, prematurity
7 M 1976 Aortic valve defect Tl, radius, left Anencephaly, VSD cleft palate,
spina bifida, hypospadias, twin
(twin brother healthy)
8 M 1977 Uterus bicornis Tl, phalanges, II-V, left
9 F 1983 Uterus bicornis It, radius, left Megacephaly, seizures
10 F 1983 Duplication ofuterus and cervix Tl, ulna, right syndactyly, II/II
single kidney
Abbreviations: T, terminal; 1, longitudinal; t, transverse; ASD, atrio-septal defect; VSD, ventriculo-septal defect; I, intercalary.
Table 5. Acute infections during pregnancy and limb reduction defects.
Case Sex Year ofbirth Maternal illness Limb defect Other anomalies
1 F 1953 Rubella Tl, thumb, right
2 F 1965 Rubella Tl, phal, right
It, leg
3 M 1970 Rubella Tl, tibia, left CHD, abnormal ears, cryptorchidism
4 F 1972 Rubella Tt, toes, right, left Father, grandfather: deformed toes
5 F 1967 Red measles Tt, hand, right
6 F 1970 Varicella Tt, tibia, fibula
7 M 1971 Viral infection Tt, radius, right Sister: deafness
8 F 1977 Viral infection Tt, hand, right
9 M 1978 Viral infection Tl, phalanges II-IV, right
Syndactyly toes IV/V, right, left
10 M 1979 Viral infection Tt, hand, left
11 M 1980 Viral infection Tt, hand, left
Abbreviations: T, terminal; 1, longitudinal; t, transverse; I, intercalary; CHD, congenital heart defect.
Table 6. Cases with documented thalidomide exposure.
Case Sex Year ofbirth Other drugs Limb defects Other anomalies
1 F 1962 - It, humeri, right, left Cleft palate, strabismus
2 F 1962 - Tl, phalanges II-V, left Nevus, flammeus, CHD
It, humeri, radii, ulnae, right, left
3 F 1962 alcohol It, humeri, radii, ulnae, femora, tibiae, Mental retardation, VSD, deafness, nevus
fibulae flameus, ring around right lower leg
Abbreviations: T, terminal; 1, longitudinal; t, transverse; I, intercalary; CHD, congenital heart defect; VSD, ventriculo-septal defect.
expression. However, without personal investigation or
access to detailedmaternalrecords,this cannotbedecided
with certainty. Inthree cases, maternaluterine anomalies
are mentioned. These again couldbe examples ofaspecific
syndrome with hand and uterus anomalies with variable
expression in different generations, such as the ulnar-
mammary syndrome (10); in one further case cleft palate
in the motherwas afeature, in two cases the motherhad a
congenital heart defect.
Acute Maternal Infections during
Pregnancy
In 11 cases acute maternal infections during pregnancy
were registered (Table 5). This included three cases of
rubella infection and one case with contact to rubella, one
case with red measles and one with varicella, and also
three casesofasevereviralinfection,butfurtherdetails of
the virus in question were not available.
Exposure to Medications, X-Rays,
Environmental Hazards, and Drugs
Thalidomide was noted in onlythree cases (Table 6) inthis
study (6). One of the cases also had prenatal alcohol
exposure. The three cases display the well-established
pattern ofanomalies caused by thalidomide, affecting the
skeletal system and causingcardiovascular andfunctional
anomalies (1). It is of interest that the case with alcohol
exposure also had mental retardation.
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Table 7. Maternal exposures in pregnancy and limb reduction defects.
Case Sex Year ofbirth Medication/exposure Limb defect Remarks
1 M 1969 Marijuana Tl, phalange, II, right
syndactyly IV/V, right
2 F 1972 Marijuana It, radius, right
It, tibiae, right, left
syndactyly I/II, IV/V, right
3 M 1979 Marijuana Tl, phalange, II, right Microcephaly, growth retardation,
syndactyly toes, III/IV peculiar face, mental retardation
4 M 1972 Diet pills Tt, hand, right
5 F 1977 Diet pills Tt, hand, right
6 F 1972 INH from 6 weeks Tl, thumb, left 46,XX, microphthalmia, small jaw,
gestation cleft palate, bulbous nose,
neonatal death, duodenal atresia
7 M 1970 Hormonal injections Tt, hand, right Hip dislocation hemangioma;
sister: duplication ofvagina
8 F 1978 Fertility drugs, Tl, phalanges IV/V, right Hip dysplasia
diazepam
9 F 1970 Gravol Tl, phalanges, II-V, right Bifid uvula
Aspirin Tl, toes II-V, right
10 F 1971 Skemetil Tt, hand, right
11 M 1973 Bonamin Tl, phalanges, II-IV, left
syndactyly IV/V, left
12 M 1982 Medication for Tl, phalange V, right
schizophrenia
13 F 1984 Cocaine, alcohol Tt, hand, right Ear dysplasia
Abbreviations: T, terminal; 1, longitudinal; t, transverse; I, intercalary.
Marijuana was documented as a drug taken in preg-
nancyinthree cases (Table 7). Cocainewas documented in
one case, which was described in detail previously (3).
Therewas asingle caseinwhichmaternal X-rayexposure
was documented. Inthiscase aterminaltransverse defect
ofthe phalanges ofthe left hand was found.
Excluded from the analysis was one case with a chro-
mosomal anomaly(ringchromosome 13) and one casewith
Poland anomaly, inwhich iron was taken as the only drug
duringpregnancyand anyrelationship to the limb defects
is very unlikely. Both cases were described previously
(6,8).
Discussion
An analysis of maternal factors with a potential
teratogenic effect was undertaken to evaluate if any spe-
cific recurring pattern could be recognized.
Itiswell established thatchildren born tomotherswith
diabetes mellitus have a two to four times increased risk
for congenital malformations. This includes cardiovascu-
lar, genitourinary, and central nervous system anomalies;
branchial arch malformations have also been described
(11). Thecaudalregressionanomalyorfemoralhypoplasia-
unusual-facies syndrome has been recognized as a devel-
opmental field defect occurring frequently in infants of
diabetic mothers (12,13). The spectrum of anomalies
describedintheliteratureisstrikinglycompatibleinthree
of the four cases where the mother was identified as
diabetic (Table 1). The teratogenic mechanism is not yet
well understood, but hyperglycemia appears to have a
greater impact in the pathogenesis of defects related to
maternal diabetes (14).
Among children of mothers treated with hydantoin
(Dilantin), the risk of showing either the full hydantoin
syndrome is 10% and for some signs of the spectrum of
anomalies is an additional 33%.As demonstrated in obser-
vations of discordant twins, the genetic background is
importantfortheexpressionofthesyndromefeatures (15).
In our study, it is unclear in three ofthe five cases which
particular medication was taken for epilepsy. However, in
two cases hydantoin in combination with other drugs was
documented and the reduction defects seen are congruent
with those described in the literature.
Theexposuretochronicmaternaldiseaseinourstudyis
very heterogeneous. For maternal arthritis, coeliac dis-
ease, and lupus erythematosus circulating antibodies,
causing placental thrombosis, have been discussed as
possible teratogens (16). Avascular disruption at various
times in development is a likely explanation for the major-
ityofcaseswithchronicmaternaldiseaseinourstudy(17)..
Maternal cardiovascular anomalies were documented in
two cases, one of them showing a very severe pattern of
associated anomalies (Table 4). This case is a product ofa
twin pregnancy, which by itself could contribute to
numerous congenital malformations. The causative factor
for the observed pattern of fetal anomalies remains
unclear.
In eight cases, other maternal congenital anomalies
wereregistered. Fourmothershadaskeletaldefect,which
was similar in the offspring and might very well demon-
stratevariableexpressionofageneticdisorder. Ofparticu-
lar interest among these cases is the occurrence of
amniotic band sequence anomalies in a mother and her
offspring. Theinfanthadinaddition aspectrumofanoma-
lies, some of them that were not due to amniotic bands.
Similar observations had been reported by Hunter and
Carpenter (18). The hypothesis was put forward that this
might be due to a familial inherent vascular instability,
leading to recurrence ofamniotic band sequence.
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Mothers ofthree cases had uterine anomalies. Uterine
anomalies have been suggested as a mechanical factor
leadingtolimb anomalies through earlyinutero compres-
sion (19). In view ofthe variable expression in the autoso-
mal dominantly inherited ulnar-mammary syndrome, at
least one case described by Graham and co-workers (19)
with ulnar-ray reduction is very suggestive for this diag-
nosis. Intwo cases from ourstudy, the offspringhadulnar
defects, suggesting the ulnar-mammary syndrome as a
likely diagnosis (10). Because personal physical examina-
tion was not possible, we cannot confirm this.
In the group of acute maternal infections, there were
four cases with prenatal rubella exposure, displaying dif-
ferentlimbreduction defects. Defects known tobepresent
in the majority of cases with congenital rubella are not
documented in the cases from our study, with one excep-
tion (congenital heart defect). The only limb defects
described in cases with congenital rubella are osteolytic
lesions (20). In ourstudythesewerenotidentified. Itis not
possible to specify the relationship between the observed
limb reduction defects in this study and the prenatal viral
infection.Amongthepathogeneticmechanismsincongeni-
tal rubella, inhibition of cell replication has beeen sug-
gested. Marked slowing ofcell doubling time could result,
among other anomalies, in reduction defects of the limbs
(21).
In fetal varicella (Table 5) limb reduction defects are
part ofthe spectrum ofcongenital anomalies described in
the literature and are frequently associated with cicatri-
cial lesions of the overlying skin (22). In the cases with
unspecified viral infections, terminal transverse defects at
the metacarpophalangeal level in the majority of cases
suggests a vascular disruption (17) and thus are a fairly
unspecific effects of a viral agent.
Thalidomide exposurewas documented inthree casesin
this study. The drugwas on the marketin Canadaforonly
11months during1962 (23).Thepatternofanomaliesfound
in this study is congruent with the expected pattern
characteristic for this teratogen (1). At least 25 different
hypotheses havebeensuggested toexplaintheteratogenic
mechanism ofthis chemical, none ofthem elucidating the
mechanism of action satisfactorily (24).
Marijuana is widely used, so the three cases present
here represent a minimal estimate of probable exposed
cases. In extended studies among marijuana users, no
significant increase in minor or major anomalies has been
identified (25), although sporadic case reports ofcongeni-
tal anomalies have been reported (26). In studies on rats,
limb reduction defects as well as other congenital anoma-
lies were found (27). The three cases of reduction defects
from our study could be a chance occurrence. However,
twoofthemhave astrikinglysimilarpattern ofanomalies,
namely, reduction defects ofthe second ray,which is avery
unusual anomaly. The incidence for middle-ray defects in
the general population in ourstudywas 0.609in10,000live
births, and adefectrestricted tothesecond rayis evenjust
a small proportion ofthis rare event (8).
In the group with miscellaneous drugs and unspecified
viral infections (Tables 5 and 7), defects ofthe distal limb
are far more frequent (19/23, 78%) than defects of the
proximal parts ofthe limbs the limbs (4/23,17%, mean =
17.04; p<0.001). This is not significantly differentfrom the
incidence of distal defects occurring among live births in
general,where distal defects occurred in 76% ofcases and
proximal defects in 24% of cases (6). A high incidence of
distal limb defects was also found in studies ofmammals
(28). An unspecific effect ofteratogenic agents interfering
with the sensitive time in limb development either as a
vascular disruption or inhibition of cell growth has been
postulated.
Other studies looking systematically for maternal fac-
tors in cases with limb reduction defects have used differ-
ent classification systems for the limb defects and
examined a different spectrum ofmaternal factors. They
are therefore difficult to compare. However, Polednak and
co-workers (29) also found diabetes mellitus being associ-
ated with "hypoplasia of the lower extremities," appar-
ently involving the long bones, in three out of five cases.
Aro(30),inastudyof453caseswithlimbreductiondefects
in Finland, foundinfluenzaand rheumatoid arthritis asso-
ciated with reduction defects ofthe limbs.
The significance of an association between maternal
factors and limb reduction defects is difficult to assess in
retrospective studies. Ingeneral, amotherofamalformed
child will more likely try to find an external cause for the
birth anomaly and may thus more actively remember any
unusual circumstances duringthe pregnancy. The figures
derived from such studies may therefore be biased. How-
ever, because of the paucity of human data, it is worth
assessing available databases for any patterns ofmalfor-
mation that appear to be associated with given exposures.
Prospective approacheswouldthenberequired to confirm
any hypothesis regarding causation. In some subgroups
from this study (mothers with diabetes, epilepsy, and
chronic maternal diseases) the limb reduction defects
resembled the pattern that is established in the literature.
Even though the numbers are small, databases on limb
reduction defects in humans are not common, and it is
worth describing and analyzing these so that, together
with other studies, insight may be gained.
The authors are grateful to Betty MacDonald, Manager, Health
Surveillance Registry, and J. Dyrland, Assistant Director, Division of
Vital Statistics, Ministry of Health, for their assistance with this study.
Strict conditions of confidentiality are maintained with respect to the
British Columbia Health Surveillance Registry data. U. G. Froster was
partlysupportedbyagrantfromtheDeutsche Forschungsgemeinschaft
(FR653/1-2). P.A. Baird is supportedbytheMedical Research Council of
Canada (MA-9279).
REFERENCES
1. Lenz, W. A short history ofthalidomide embryopathy. Teratology 38:
203-215 (1988).
2. Hanson, J. W., and Smith, D. W. The fetal hydantoin syndrome. J.
Pediatr. 87: 285 (1975).
3. Froster, U. G., and Baird, P A. Congenital defects of the limbs and
alcohol exposure in pregnancy: data from a population based study.
Am. J. Med. Genet. 44: 782-785 (1992).
4. Hoyme, H. E., Jones, L. K., Dixon, S. D., Jewitt, T., Hanson, J. W.,
Robinson, L. K., Msall, M. E., and Allanson, J. E. Prenatal cocaine274 FROSTER AND BAIRD
exposure and fetal vascular disruption. Pediatrics 85: 743-747
(1991).
5. Firth, H. V., Boyd, P. A., Chamberlain, P., MacKenzie, I. Z, Linden-
baum, R.H., andHuson, S.M.Severelimbabnormalitiesafterchorion
villus sampling at 55-66 days gestation. Lancet i: 762-763 (1991).
6. Froster-Iskenius, U. G., and Baird, P. A. Limb reduction defects in
overonemillion consecutivelivebirths. Teratology39: 127-135 (1989).
7. Baird, P. A. Measuring birth defects and handicapping disorders in
the population: the British Columbia Health Surveillance Registry.
Can. Med. Assoc. J. 136: 109-111 (1987).
8. Froster, U. G., and Baird, P. A. Congenital defects ofthe upper limbs
and associated malformations: apopulationbased study. Am. J. Med.
Genet. 44: 767-781 (1992).
9. Johnson, J. P., Carey, J. C., Gooch, M. W., Petersen, J., and Beattie, J.
F. Femoral hypoplasia-unusual facies syndrome ininfants ofdiabetic
mothers. J. Pediatr. 102: 866-772 (1983).
10. Meinecke, P., Stier, U., and Blunck, W. Normal hands and feet in the
ulnar-mammarysyndrome. Dysmorphol. Clin. Genet.3: 61-64 (1989).
11. Johnson, J. P., and Fineman, R. M. Branchial arch malformations in
infants of diabetic mothers: two case reports and a review. Am. J.
Med. Genet. 13: 125-130 (1982).
12. Williamson, D.A.J.Asyndrome ofcongenitalmalformations possibly
duetomaternal diabetes. Dev. Med. Child. Neurol. 12: 145-152(1970).
13. Riedel, F., and Froster-Iskenius, U. Caudal dysplasia and femoral
hypoplasia-unusual facies syndrome: different manifestations ofthe
same disorder? Eur. J. Pediatr. 144: 80-82 (1985).
14. Cousins, L. Congenital anomalies amonginfants ofdiabetic mothers.
Am. J. Obstet. Gynecol. 147: 333-338 (1983).
15. Finell, R. H., and Chernoff, G. F. Editorial comment: genetic back-
ground: the elusive component in the fetal hydantoin syndrome. Am.
J. Med. Genet. 19: 459-462 (1984).
16. Harris, E. N., Chan, J. K. H.,Asherson, R.A.,Aber, V. R., Gharavi,A.
E., and Hughes, G. R. V. Thrombosis, recurrent fetal loss and throm-
bocytopenia. Arch. Intern. Med. 146: 2153-2156 (1986).
17. Hoyme, H. E., Jones, K. L., van Allen, M. I., Sanders, B. S., and
Benirschke, K. Vascular pathogenesis of transverse limb reduction
defects. J. Pediatr. 101: 839-843 (1982).
18. Hunter, A. G. W., and Carpenter, B. F. Implications ofmalformations
notdueto amniotic bandsin the amniotic bandsequence.Am. J. Med.
Genet. 24: 691-700 (1986).
19. Graham, J. M., Miller, M. E., Stephan, M. J., and Smith, D. W. Limb
reduction anomalies and early in utero limb compression. J. Pediatr.
96: 1052-1056 (1980).
20. Jones, K. L. Smith's Recognizable Patterns ofHuman Malformation,
4th ed. W. B. Saunders Company, Philadelphia, 1988, pp. 510-511.
21. South, M.A.,andSever,J. L.Teratogenupdate: thecongenitalrubella
syndrome. Teratology 31: 297-307 (1985).
22. Laforet, E. G., and Lynch, C. L. Multiple congenital defects following
maternal varicella. N. Engl. J. Med. 236: 534-537 (1947).
23. Webb,J.T.Canadianthalidomideexperiences.Can.Med.Assoc.J.89:
987-992 (1963).
24. Stephens, T. D. Proposed mechanisms of action in thalidomide
embryopathy. Teratology 38: 229-239 (1988).
25. Shepard, T. H. Catalog ofTeratogenic Agents, 6th ed. John Hopkins
University Press, Baltimore, MD, 1989.
26. Hecht, F.,Beals, R.K., Lees,M.H.,Jolly, H., andRoberts, P. Lysergic-
acid-diethylamideandcannabisaspossibleteratogensinman. Lancet
ii: 1087 (1968).
27. Persaud,T.V. N.,andEllington,A. C.Teratogenic activityofcannabis
resin. Lancet ii: 406-407 (1968).
28. Sanders, D. D., and Stephens, T. D. Review of drug-induced limb
defects in mammals. Teratology 44: 335-354 (1991).
29. Polednak, A. P., and Janerich, D. T. Maternal factors in congenital
limb reduction defects. Teratology 32: 41-50 (1985).
30. Aro, T. Maternal diseases, alcohol consumption and smoking during
pregnancyassociatedwithreductionlimbdefects. EarlyHum. Dev.9:
49-57 (1983).